Our country has an advanced system of safety testing and regulation in place to ensure medications are safe. We assume the pharmaceutical drugs prescribed by our doctors are beneficial for our health. Yet in too many cases, pharmaceutical drugs cause severe health problems that rival the conditions they were intended to treat.
At no fault of their own, countless Americans suffer from severe health problems and die wrongfully as a result of a dangerous drug. Pharmaceutical companies cut corners to increase profits, and release dangerous and defective drugs onto the market.
The Onder Law Firm specializes in representing individuals and families against large, billion-dollar pharmaceutical corporations. In many cases, it is only the threat of litigation that spurs pharmaceutical companies to take action to recall a dangerous drug or add a warning to a product's label. Our attorneys handling pharmaceutical litigation endeavor to win meaningful compensation to safeguard a family's financial future following medical emergencies or loss stemming from a dangerous drug.
If you believe you or a family member was harmed by a dangerous or defective drug, you may have grounds to file a claim. Pharmaceutical lawsuits can bring about needed monetary compensation to cover medical expenses, lost work, and long-term care - and they also serve to prevent future suffering. When companies are faced with major litigation for dangerous pharmaceuticals, they are more likely improve the safety of their drugs.
Androgel and other testosterone replacement therapies have been found to pose serious cardiac health risks to men. Furthermore, there is no evidence to suggest many men stand to benefit from taking testosterone replacements like Androgel. False and misleading advertising has led thousands of men to take testosterone therapy, completely unaware of the health risks and at no fault of their own. Read more about AndroGel and other testosterone drug lawsuits.
Approved by a fast track FDA process, Invokana is a drug prescribed to Type II diabetics that has been found to cause serious health problems including kidney failure, ketoacidosis, cardiac problems, and death. Used as a method of glycemic control, medical experts now suggest Invokana risks outweigh the drug's benefit. Invokana is a drug sold by Janssen, a subsidiary of Johnson & Johnson, and has been the subject of FDA warnings. Read more about Invokana lawsuits.
This popular antibiotic, which is used to treat respiratory and urinary tract infections, was the subject of two independent medical studies that were published in 2015. Both studies concluded that current and former Levaquin use can weaken the aorta, the largest artery in the body. Having used Levaquin doubled the risk of potentially life threatening aortic aneurysm and aortic dissection. Read more about Levaquin lawsuits.
These heartburn and acid reflux medications, a class of drugs known as proton pump inhibitors, were the focus of a 13-year medical study that concluded ongoing use of the medications place users at a 50% higher risk of Chronic Kidney Disease. They are some of the most widely used drugs in the world and have made their makers billions of dollars and now hundreds of millions of people may have been exposed to a seriouos disease. Read more about Nexium/Prilosec/Prevacid lawsuits.
Onglyza and Kombiglyze XR are Type 2 diabetes drugs manufactured by AstraZeneca. The FDA added a Heart Failure Warning to the product labels of these drugs in April of 2016. Although relatively new to the market, both have been widely used, leaving hundreds of thousands of current and former users at a greater risk of developing heart failure. Read more about Onglyza and Kombiglyze XR lawsuits.
Risperdal is an antipsychotic prescribed to children, adolescents, and adults who suffer from Bipolar I Disorder, autism, and schizophrenia that has been found to cause the growth of breasts in boys and young men. The condition, which is known as gynecomastia, is less a medical condition than an emotional one, though surgery is often required to remedy the physical condition. A best-selling drug of Johnson & Johnson, off-label and fraudulent advertising allegations were settled in a record $2.2 billion dollar settlement with the United States Justice Department. Read more about Risperdal lawsuits.
Tasigna is a drug for treating Philadelphia chromosome-positive chronic myeloid leukemia. Medical research has found that it causes severe and rapidly developing atherosclerosis in as many as one-fourth of its users. This can result in peripheral arterial disease, which may result in amputation of one or more limbs in severe cases. Read more about Tasigna atherosclerosis lawsuits.
Taxotere is a chemotherapy drug that that has been found to cause permanent hair loss. Although hair loss is a common side effect of many chemotherapy drugs, that is only temporary. In many cases, those who have used Taxotere have been left with permanent baldness, patchy or clumpy hair. There was no warning of the potential for permanent hair loss, despite the drug's manufacturer being aware of this risk for over a decade. Read more about Taxotere hair lawsuits.
Xarelto is a popular anti-coagulant that is now known to cause high rates of serious and potentially fatal internal bleeding. Intended to prevent stroke but inhibiting the formation of blood clots, Xarelto is perhaps more dangerous than it is beneficial. There is no antidote to stop Xarelto internal bleeding, and patients were not fairly warned of the risk for serious bleeding events. Read more about Xarelto lawsuits.
An anti-nausea medication, Zofran has been widely prescribed to pregnant women despite never having been tested for that use. Studies now show that babies exposed to Zofran in utero, particularly during the first trimester, are at risk for developing a range of birth defects including congenital heart defects and cleft palate. GlaxoSmithKline settled a lawsuit with the Department of Justice for $3 billion, in part for promoting Zofran for use in pregnany women. Read more about Zofran lawsuits.
Scott G Williams MD, FACOG
Dr Williams is a board certified obstetrician/gynecologist who serves as chief medical consultant for Onder Law. During more than 20 years as a practicing ob/gyn in St Charles county, Dr Williams delivered thousands of babies, performed surgery on a daily basis, and was considered one of the top providers in his profession. He served as chief of ob/gyn at two of the three hospitals in St Charles county, and currently is the full time medical director of St Louis area obstetric hospitalist program.
In addition, Dr Williams has served as a long time consultant in medical and pharmaceutical litigation for Onder Law. With a background that includes scientific research as well as medical practice, Dr Williams is adept at interpreting pharmaceutical and medical device studies. His past analyses have included research on the harmful effects of contraceptive devices, talc/ ovarian cancer and the blood clotting effects of certain oral contraceptives.
Clients would not commonly meet with Dr Williams as he is not an attorney, but his expertise forms an important part of Onder Law's client strategies for medical and pharmaceutical products. Dr Williams is often a crucial "behind the scenes" part of formulating a winning approach for your case.
Scott G Williams, MD, FACOG, is a 1986 graduate of the University of Notre Dame. His MD was earned at the University of Missouri Columbia and he completed residency at the well regarded University of Florida-Gainesville Ob/Gyn program. Dr Williams and his wife (who is also a physician) live with two labrador retrievers; their son and daughter are at college.